Associate Professor of Radiation Oncology, Thomas Jefferson University
Radiation Oncology
Dr. Pramila R. Anne, MD
|
|
Give Review
Pramila Anne practices Radiation Oncology. She went to University of Virginia School of Medicine. She has 3 awards "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Top MD". Pramila R. Anne, MD is a published MD as well. She has 31 publications published. The latest was: A dosimetry system for 192IR interstitial breast implants performed at the time of lumpectomy. She accepts all Medicare patients.
Publications
- Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomog...
- Impact of a Radiation Oncology Elective on the Careers of Young Physicians: Update on a Prospective Cohort Study.
- Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN).
- Implementation and experimental results of 4D Tumor tracking using robotic couch.
- Radiation therapy for locally recurrent Breast cancer.
- Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies.
- Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiother...
- A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck Cancer.
- Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and Breast irradiation for early stage Breast cancer: an exploratory an...
- Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).
- Cholangiocarcinoma: the impact of Tumor location and treatment strategy on outcome.
- Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma.
- Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck Cancer.
- A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck Cancer.
- Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left Breast cancer: report of a prospective trial.
- Side-Branch Embolization Before 90Y Radioembolization: Rate of Recanalization and New Collateral Development.
- Toxicities After Radioembolization With Yttrium-90 SIR-Spheres: Incidence and Contributing Risk Factors at a Single Center.
- Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.
- Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx Cancer.
- The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma.
- Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck Cancer.
- Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal Cancer? A two-...
- Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate Cancer.
- A dosimetry system for 192IR interstitial Breast implants performed at the time of lumpectomy.
- Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
- The use of mixed-integer programming for inverse treatment planning with pre-defined field segments.
- Microsatellite status and cell cycle associated markers in rectal Cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy.
- Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report.
- Inverse treatment planning using volume-based objective functions.
- Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric Cancer (RTOG-0114).
Schools
University Of Virginia School Of Medicine
Massachusetts General Hospital
Harvard University School Of Medicine
Procedures Preformed
- Brachytherapy
- External Beam Radiotherapy
- High-Dose Rate (HDR) Brachytherapy
- Image-Guided Radiation Therapy (IGRT)
- View All
Conditions Treated
- Breast Cancer
- Malignant Tumor of the Head and-or Neck
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Massachusetts General Hospital -
University of Virginia School of Medicine
Hospital
-
Thomas Jefferson University Hospital
Drug Facts
| NPI NUMBER | 1982626321 | |
| NPPES Provider LastName | ANNE | |
| NPPES Provider FirstName | PRAMILA | |
| NPPES Provider ZIPCode | 191074824 | |
| NPPES Provider State | PA | |
| Specialty Description | Diagnostic Radiology | |
| Total Claim Count | 202.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 6.93 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982626321 |
| Last Name Of The Provider | ANNE |
| First Name Of The Provider | PRAMILA |
| View All |
Similar Doctors
|
Dr. Hanmanth J. Neboori, MD |
|
|
Dr. Reid F. Thompson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Ojerholm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anusha Kalbasi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zelig A. Tochner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert A. Lustig, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. James M. Metz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Priya Mitra, MD
This Doctor is OpenDoctor Recommended.
|